The essential role of sex and gender in atherosclerosis research: A statement from the Editorial Board of Atherosclerosis and Executive Committee of the European Atherosclerosis Society
Atherosclerosis. 2025 Jun 30:407:120403.
doi: 10.1016/j.atherosclerosis.2025.120403.
Online ahead of print.
1 Editorial Board Atherosclerosis, Kingdom of Sweden; Executive Committee European Atherosclerosis Society, Kingdom of Sweden; Department of Internal Medicine, Erasmus MC Cardiovascular Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands. Electronic address: j.roetersvanlennep@erasmusmc.nl.
2 Editorial Board Atherosclerosis, Kingdom of Sweden; Executive Committee European Atherosclerosis Society, Kingdom of Sweden; Wihuri Research Institute, Helsinki, Finland; Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.
3 Editorial Board Atherosclerosis, Kingdom of Sweden; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
4 Editorial Board Atherosclerosis, Kingdom of Sweden; Institute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
5 Editorial Board Atherosclerosis, Kingdom of Sweden; Section of Cardiovascular Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, United Kingdom.
6 Editorial Board Atherosclerosis, Kingdom of Sweden; Department of Medicine and Division of Cardiology, University of Alberta, Edmonton, AB, Canada.
7 Executive Committee European Atherosclerosis Society, Kingdom of Sweden; Department of Clinical Biochemistry, Copenhagen University Hospital, Rigshospitalet, Centre of Diagnostic Investigation, Copenhagen, Denmark.
8 Executive Committee European Atherosclerosis Society, Kingdom of Sweden; Copenhagen University Hospital - Herlev and Gentofte, Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
9 Executive Committee European Atherosclerosis Society, Kingdom of Sweden; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Norwegian National Network for FH, Oslo University Hospital, Oslo, Norway.
10 Executive Committee European Atherosclerosis Society, Kingdom of Sweden; Ege University Medical Faculty, Department of Cardiology, Bornova, Izmir, Turkey.
11 Executive Committee European Atherosclerosis Society, Kingdom of Sweden; Klinik und Poliklinik für Kardiologie, Universität Leipzig, Leipzig, Germany.
12 Executive Committee European Atherosclerosis Society, Kingdom of Sweden; First Department of Propaedeutic Internal Medicine, Medical School, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
13 Executive Committee European Atherosclerosis Society, Kingdom of Sweden; Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College, London, United Kingdom.
14 Editorial Board Atherosclerosis, Kingdom of Sweden; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.